Literature DB >> 3025204

Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents.

M Kuroda, R C Honnor, S W Cushman, C Londos, I A Simpson.   

Abstract

This paper examines the modulation of insulin-stimulated glucose transport activity in rat adipose cells by ligands for receptors (R) that mediate stimulation (Rs; lipolytic) or inhibition (Ri; antilipolytic) of adenylate cyclase. The changes in glucose transport activity and cAMP, as assessed by 3-O-methylglucose uptake and (-/+) cAMP-dependent protein kinase (A-kinase) activity ratios, respectively, were monitored under conditions that maintain steady-state A-kinase activity ratios (Honnor, R. C., Dhillon, G. S., and Londos, C. (1985) J. Biol. Chem. 260, 15122-15129). Removal of endogenous adenosine with adenosine deaminase decreased insulin-stimulated glucose transport activity by approximately 30%, which was prevented or restored with Ri agonists such as phenylisopropyladenosine, nicotinic acid, and prostaglandin E1. These changes in transport activity were not accompanied by changes in A-kinase activity ratios, indicating that Ri-mediated effects on transport are independent of cAMP changes. Addition of an Rs ligand, isoproterenol, in the presence of adenosine increased kinase activity but did not change glucose transport activity. Conversely, upon removal of adenosine, addition of Rs ligands such as isoproterenol, adrenocorticotropic hormone, or glucagon strongly inhibited transport (approximately 50%) and stimulated kinase activity. However, subsequent addition of phenylisopropyladenosine nearly restored transport activity without alteration of A-kinase activity. These data and additional kinetic experiments suggest that Rs-mediated glucose transport modulations are also independent of cAMP. The interchangeability of ligands for both Rs and Ri receptors in modulating transport activity suggests that these cAMP-independent effects are mediated by the stimulatory (Ns) and inhibitory (Ni) guanyl nucleotide-binding regulatory proteins of adenylate cyclase. All Rs-and Ri-induced changes in transport activity occurred without a change in glucose transporter distribution, as assessed by D-glucose-inhibitable cytochalasin B binding, suggesting that Rs and Ri ligands modulate the intrinsic activity of the glucose transporter present in the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025204

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase.

Authors:  Sameer Mohammad; Lavoisier S Ramos; Jochen Buck; Lonny R Levin; Francesco Rubino; Timothy E McGraw
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

2.  Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus.

Authors:  W T Garvey; T P Huecksteadt; S Matthaei; J M Olefsky
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Characterization of GTP-binding proteins in Golgi-associated membrane vesicles from rat adipocytes.

Authors:  A Schürmann; W Rosenthal; G Schultz; H G Joost
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

4.  Phosphorylation of the adipose/muscle-type glucose transporter (GLUT4) and its relationship to glucose transport activity.

Authors:  A Schürmann; G Mieskes; H G Joost
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

5.  G(alpha)11 signaling through ARF6 regulates F-actin mobilization and GLUT4 glucose transporter translocation to the plasma membrane.

Authors:  A Bose; A D Cherniack; S E Langille; S M Nicoloro; J M Buxton; J G Park; A Chawla; M P Czech
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle.

Authors:  J W Ryder; Y Kawano; A V Chibalin; J Rincón; T S Tsao; A E Stenbit; T Combatsiaris; J Yang; G D Holman; M J Charron; J R Zierath
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 7.  The role of G proteins in transmembrane signalling.

Authors:  C W Taylor
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

8.  Isoproterenol inhibits cyclic AMP-mediated but not insulin-mediated translocation of the GLUT4 glucose transporter isoform.

Authors:  S L Macaulay; A S Kelada; J Proietto
Journal:  Mol Cell Biochem       Date:  1994-12-07       Impact factor: 3.396

9.  Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance.

Authors:  Maria Helena M Lima; Mirian Ueno; Ana Cláudia P Thirone; Eduardo M Rocha; Carla Roberta O Carvalho; Mário J A Saad
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

10.  Isoproterenol stimulates phosphorylation of the insulin-regulatable glucose transporter in rat adipocytes.

Authors:  D E James; J Hiken; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.